Lecture 13 Flashcards
Pain Management
Are patients with pain usually under or overtreated?
Undertreated
Are the pathophysiologic mechanisms for pain well understood?
No, they are complex and usually do not translate into necessary skills for managing pain in most patients.
Marks & Sachar
Evidence of Undertreatment
- 1973
- 38 inpatients treated for pain
- 37% continued to experience severe distress and 41% experienced moderate distress despite analgesics
- Chart reviews showed records of significant undertreatment compared to doses ordered and knowledge deficits among physicians
Brescia et al
Evidence of Undertreatment
- 1992
- 1103 patients hospitalized with advanced cancer
- 73% had pain upon admission
- Only 36% received regular, around-the-clock dosing
- Actual pain amount not assessed
Anand et al
Evidence of Undertreatment
- 1992
- Neonates undergoing cardiac surgery were either given deeper anesthesia with higher doses of opioids post-surgery or lower doses of each
- Those who had deeper anesthesia and higher doses of opioids had decreased stress responses and lower incidents of sepsis, acidosis, clotting, and death
Cleveland et al
Evidence of Undertreatment
- 1994
- Examined pain control in outpatients with cancer treatment
- 42% of 597 patients had inadequate analgesic therapy
- Patients at centers serving predominantly minorities were 3x more likely to be undertreated
- Discrepancy between patient and physician judgement of pain severity
Reasons for Undertreatment (5)
- Lack of routine assessment
- Lack of Advocacy
- Lack of prescriber and patient education
- Lack of multidisciplinary team-based care
- Lack of availability
Lack of Assessment
- Pain isn’t visible if it isn’t assessed and documented
- Examples of assessment scales - 0-10, smiley scales
- Patients are best judge of their pain severity
Lack of Advocacy
- Patients may not advocate for their own analgesia out of concerns that they’ll be viewed as malingering or drug seeking
- Health professionals may need to be the patient’s advocate
- May need to change the system in order to provide routine pain assessments or hire anesthesiologists or intensivists to provide aggressive analgesic support (use propofol/fentanyl) for children’s pain
Lack of Multidisciplinary Teams
-Critical for patients with more complex chronic pain syndromes
Lack of Availability
- Opioids may be unavailable for patients with severe pain in inner city neighborhoods (esp. in minority neighborhoods)
- Studies showing this may not be accurate based on calling pharmacists and pharmacists not providing truthful information
- NM study by the COP showed the opposite of this and that availability wasn’t a concern and that pharmacists were willing to order opioids for those with severe pain
- Perceived lack of availability may be related to underprescribing of opioids to minority patients
Bastian et al, Psychological Science
- Study using experimental pain and its connection with guilt
- Revealed that those who had identified as feeling guilty from a recent event felt less pain when exposed to the ice water bath
- Guilt ratings then drop after the exposure, suggesting a cathartic effect
Regulatory Concerns (2)
- Growing fear of prosecution among providers
2. Concerns of addiction, tolerance, and toxicity
Fear of Prosecution
- Connected to marked increase of opioid overdoses in recent years
- Most overdoses are connected to misuse or lack of education between prescribers, patients, and relatives
- Can also be connected to pill mills or healthcare system problems like fee for service
- Mismanagement, lack of team-based care, and lack of adequate patient education/follow-ups all lead to overdoses
- The push back of under-prescribing patients with legitimate pain will likely be significant due to this
Concerns of Addiction/Tolerance/Toxicity
- Includes physical dependence, tolerance, and physiological dependence (cravings)
- Patients with no addiction history have not been shown to develop it from appropriate analgesic therapy
- Addiction usually developed at a young age and is connected to genetic predisposition and socialization in early life, not by using opioids
- One opioid isn’t less addictive than another
Respiratory Depression
Possible side effect of using opioids. Doesn’t occur when using opioids that are doses and titrated appropriately
Types of Pain (3)
- Acute
- Malignant
- Chronic/Non-malignant
Acute Pain
- Immediate pain due to an obvious injury
- Managable with various analgesics
- Mild - Moderate: NSAID possible with opioids as well
- Severe: Opioids
Malignant Pain
- Can be acute and readily response to chemotherapy initiation
- Short term opioid treatment is usually sufficient
- Can be chronic, usually after failure of chemotherapy. Use long term opioid therapy
Chronic/Non-Malignant
- Examples: low back pain, fibromyalgia, arthritis, neuropathic pain
- Requires combination of analgesic therapy (NSAIDs + Opioids +/- adjuvant medications) in conjunction with other interventions (counseling, chiropractics, relaxation)
- Most poorly understood and hard to control
- Most likely to be undertreated and associated with opioid-related problems
- Opioids minimize suffering in this case but aren’t the main solution
Factors that Influence Pain Perception
- Many factors alter pain perception
- Include emotional state, past experience with pain, and cultural factors
- Child’s cognitive development, learned behaviors, and emotional distress effect their perception of pain
Appropriate Management of Pain
- Several simple principles allow for appropriate management
- Choice & use of agent, titration, use of adjuvants, management of adverse events, adjustment of route of administration
- Multiple opioids are almost never necessary or appropriate
- Goal is <3 on a 0-10 scale
Opioid
Morphine or other agonist of mu receptor
Non-opioid
Non-morphine like analgesic (NSAID)
Adjuvant
Usually antidepressants or anticonvulsants
Bone Pain
- Example: Infiltration of a malignancy into bony tissue that causes the release of prostaglandins and increased nerve sensitivity
- Consider an agent that lowers prostaglandin synthesis (NSAID)
Neurogenic
- Example: From infiltration of a malignancy into nervous tissue or from damage to nervous tissue
- Can result in abnormal nervous transmission and often “burning or shooting” pain
- Usually doesn’t respond well to Opioids and may require an adjuvant
Tolerance
- Can be partially mediation by NMDA stimulation
- May require use of opioid with NMDA antagonist activity or use of an adjuvant with NMDA antagonist activity (ketamine)
Goals of Pain Control (3)
- Pain free at night
- Pain free at rest
- Pain free upon movement
Use of Analgesics
- Use appropriate analgesic for type of pain
- Use regularly scheduled doses to anticipate and prevent pain
- Titrate dose to patient’s specific analgesia
- Use smaller doses in the elderly or with those who have hepatic or renal impairment
- Prevent adverse effects and be aware of dose-limiting adverse effects
- Avoid combinations of drugs with same mechanism of action
Opioids Properties (3)
- Titratability
- Tolerability
- Tolerance
Titratability
- Choose an agent with a short half-life to allow for rapid titration
- Opioids with long half-lives should be reserved for special situations
Tolerability
- Some opioids release histamine and can lead to severe urticaria
- All opioids cause constipation, but severe pain can also cause ileus especially when not properly managed
Tolerance
- Will eventually develop to most most opioids with chronic dosing which may require dosage increases
- Those with tolerance may be converted to low doses of methadone since this doesn’t have a cross-tolerance with other opioids
Approaching a Patient (2)
- Be familiar with patient, their type and degree of pain, and their analgesic needs (to validate orders).
- Pharmacists can provide valuable assistance but are often unengaged.
Services Pharmacists can Provide
- Educating patients about opioids – what to do, what not to do, how to manage adverse effects, medication storage/security, etc.
- Titrating analgesics
- Simplifying analgesic regimens (eliminating duplicative medications)
- Managing adverse effects
- Dispelling myths
- Following up with patients to optimize use